Virta Health

Virta Health delivers a digital therapeutic for type 2 diabetes reversal through nutritional ketosis, continuous remote monitoring, and medical provider supervision. Raised $400M+. Valued at $2B+. Published 5-year outcomes data. Peer-reviewed in Frontiers in Endocrinology and other journals. Treats diabetes, obesity, and metabolic syndrome.

Virta has the strongest clinical evidence among digital therapeutics for a disease-reversal claim — published in peer-reviewed journals showing diabetes reversal in 60%+ of completers — which sets it apart from symptom-management DTx.

virtahealth.com Digital Therapeutics

United Statesprivate

At a glance

Total raised

$373M

last round series e

Headcount

1k-5k

approximate · public range

Headquarters

Denver

United States

Founded

2014

12 years active

Status

Private

Digital Therapeutics

Latest valuation

$2B

Series E · 2021

For subscribers

Subscribe to see the full profile

Including Funding rounds, Bull / Bear thesis, Stock + earnings, Roster changes, Patents, News, and Open roles.

Founding

50% off

/month

94 of 100 spots left

Full

$10

/month

Available once all 100 Founding Member spots are claimed.

Get full access

Already subscribed? Sign in →

Funding history

Total raised

$373M

Rounds tracked

Latest stage

Series E

Latest valuation

$2B

Date	Stage	Amount	Valuation	Lead investors
Apr 8, 2021	Series E	$133M	$2B	Tiger Global Management
Dec 2, 2020	Series D	$65M	$1.1B	Sequoia Capital Global Equities
Jan 24, 2020	Series C	$93M	—	Caffeinated Capital
Apr 4, 2018	Series B	$45M	—	Founders Fund, Playground Global
Mar 8, 2017	Series A	$37M	—	Venrock, Obvious Ventures

Founder backgrounds

Sami Inkinen

Chief Executive Officer & Co-Founder

Previously co-founded Trulia, the online real estate marketplace, serving as its COO and President through its IPO and eventual acquisition by Zillow Group. Holds an MSc in Engineering Physics from Helsinki University of Technology and an MBA from Stanford Graduate School of Business. A competitive triathlete and age-group world champion, he was diagnosed with prediabetes despite an elite athletic regimen—a personal shock that led him to reverse the condition through nutritional ketosis and directly inspired the founding of Virta Health. He has described himself as an "incurable data geek," and that measurement-driven mindset bridges his real estate and health-technology careers. In his telling, if you can measure it, you can improve it.

AI bull / bear

Bull case

Virta’s core advantage is clinical evidence no other digital therapeutic can match: peer-reviewed, five-year outcomes data demonstrating type 2 diabetes reversal in roughly 60% of completers. That is not symptom management — it is a disease-modifying claim backed by published science. The nutritional ketosis protocol, paired with continuous remote monitoring and provider oversight, creates a care-delivery moat far deeper than an app alone. Payers and self-insured employers facing runaway GLP-1 costs have a powerful incentive to steer toward a non-pharmacologic alternative with durable results and a fraction of the long-term drug spend. The $373 million raised and $2 billion valuation, with Tiger Global anchoring the Series E, provided a capital runway to invest in clinical validation while competitors raced to market with thinner evidence. As value-based care expands, Virta’s ROI narrative — reduced medication deprescribing, avoided ER visits, and lower complication rates — aligns squarely with what risk-bearing entities want to buy.

Bear case

GLP-1 receptor agonists represent an existential threat. Drugs like semaglutide and tirzepatide deliver glycemic control and weight loss through a weekly injection, demanding zero behavior change. Virta requires patients to sustain nutritional ketosis indefinitely — adherence rates outside clinical-trial conditions are a persistent, unanswered question, and the “completers” framing sidesteps likely attrition in real-world deployment. The $2 billion valuation dates to a 2021 funding environment that no longer exists. Tiger Global has since retrenched aggressively; the absence of any new round in nearly four years raises serious questions about cash position and whether Virta can avoid a punishing down round. Meanwhile, the digital therapeutics sector has been a commercial graveyard — Pear Therapeutics liquidated despite FDA authorization, and payer willingness to reimburse DTx remains unproven at scale. Employers weighing GLP-1 coverage against Virta’s per-member fees may choose the path of least resistance: a prescription, not a lifestyle overhaul.

Generated by deepseek-v4-pro · May 2, 2026Refreshes quarterly · see disclosures

In the news

Virta Health · last 30 days

No articles ingested yet for Virta Health. Once the hourly news pipeline is live, every article the classifier tags as mentioning this company appears here with its one-line AI summary and sentiment.

Watch

Leadership

Sami Inkinen

Chief Executive Officer & Co-Founder

Amit Shah

President

—

Laura Walmsley

Chief Commercial Officer

—

Dan Hang

Chief Product Officer

—

Lucia Guillory, PhD

Chief People Officer

—

Adam Wolfberg, MD, MPH

Chief Medical Officer

—

Manu Diwakar

Chief Technology Officer

—

Products

Virta Type 2 Diabetes Reversal Treatment
Virta's flagship program is a medically supervised, nutrition-based treatment designed to reverse type 2 diabetes through well-formulated nutritional ketosis. Members receive personalized care from a physician-led team, one-on-one health coaching, continuous remote monitoring of blood glucose and ketones, and educational tools. The program has been clinically proven to lower blood sugar and A1c while reducing or eliminating diabetes medications in as little as 10 weeks, with sustained reversal outcomes at one year.
Virta Weight Loss Program
Virta's weight management program combines the same nutrition-based approach with support for GLP-1 medication therapy where appropriate. Members get personalized nutrition plans, continuous remote monitoring, health coaching, and medical supervision to achieve sustainable weight loss. The program differentiates itself by addressing metabolic health holistically rather than relying solely on medication, helping members lose weight and keep it off while improving overall metabolic markers.
Virta Mobile App
The Virta mobile application serves as the digital hub for members, enabling them to log meals, track blood glucose and ketone levels, communicate with their care team and health coach, access educational content including videos and recipes, and connect with a private online support community. The app powers the continuous remote monitoring and personalized care model that makes Virta's program scalable and accessible from anywhere.

Open roles

View all careers ↗